Viewing Study NCT00006456



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00006456
Status: COMPLETED
Last Update Posted: 2010-02-24
First Post: 2000-11-06

Brief Title: Stereotactic Radiosurgery in Treating Patients With Liver Metastases Lung Metastases or Other Advanced Solid Tumors
Sponsor: Virginia Commonwealth University
Organization: Virginia Commonwealth University

Study Overview

Official Title: Fractionated Stereotactic Body Radiosurgery for Extracranial Tumors
Status: COMPLETED
Status Verified Date: 2010-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: RATIONALE Stereotactic radiosurgery delivers x-rays directly to the tumor and may cause less damage to normal tissue

PURPOSE Phase II trial to study the effectiveness of stereotactic radiosurgery in treating patients who have liver metastases lung metastases or other advanced solid tumors
Detailed Description: OBJECTIVES

Determine the feasibility of fractionated stereotactic body radiosurgery in patients with advanced extracranial tumors
Assess the toxicities of this treatment regimen in these patients
Determine tumor response and cause of death in these patients treated with this regimen

OUTLINE Patients receive fractionated stereotactic body radiosurgery over 30 minutes for 5-10 days for a total of 3 treatments

Patients are followed every 3 months

PROJECTED ACCRUAL A total of 10-25 patients will be accrued within 2-3 years

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
NCI-V00-1612 US NIH GrantContract None httpsreporternihgovquickSearchP30CA016059
P30CA016059 NIH None None
MCV-MCC-9812-2C None None None